Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Nantes
Clinical trial register · France

Clinical Trials in Nantes, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9697 matching records held by the registry are in this view. Synced 26 Oct 2026, 03:20 UTC
9697
Studies in scope
all four open statuses
6025
Recruiting now
open to new participants
1033
Lead sponsors
across recruiting studies
Top sites
Paris 51 Lille 43 Nantes 35 Lyon 33 Marseille 25
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Nantes University Hospital176 Janssen Research & Development, LLC35 AstraZeneca27 Novartis Pharmaceuticals25 Sanofi17 Clear sponsor filter
Site location
Paris51 Lille43 Nantes35 Lyon33 Marseille25
All 67 locations
Target enrolment
to

Trials with a site in Nantes

35 of 9697 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Recruiting
Janssen Research & Development, LLC
Phase 3
1,000
Nantes, Pierre-Bénite
2026-09-09
Recruiting
Janssen Research & Development, LLC
Phase 2
230
Argenteuil, Bayonne, Le Mans, Nantes
2026-06-30
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Amiens, Lyon, Montpellier, Nantes, Poitiers, Talence, Toulouse, Tours
2026-05-31
Recruiting
Janssen Research & Development, LLC
Phase 3
644
Amiens, Besançon, Clichy, Le Kremlin-Bicêtre, Lille, Montpellier, Nantes, Nice
2026-05-23
Recruiting
Janssen Research & Development, LLC
Phase 3
460
Besançon, Clichy, Le Kremlin-Bicêtre, Lille, Montpellier, Nantes, Nice, Pessac
2026-05-22
Recruiting
Janssen Research & Development, LLC
Phase 3
530
Amiens, Clermont-Ferrand, Échirolles, Marseille, Nantes, Neuilly-sur-Seine, Nîmes, Paris
2026-04-21
Recruiting
Janssen Research & Development, LLC
Phase 3
400
Lille, Lyon, Nancy, Nantes, Paris, Pessac, Poitiers, Toulouse
2026-02-04
Recruiting
Janssen Research & Development, LLC
Phase 2/3
1,092
Bayonne, Clermont-Ferrand, Créteil, Échirolles, Lille, Montfermeil, Montpellier, Nantes
2025-10-03
By invitation
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
NCT06788509Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes
DrugsJNJ-75348780·JNJ-87801493·JNJ-80948543·Ibrutinib
Janssen Research & Development, LLC
Phase 1
120
Lille, Nantes, Villejuif
2024-12-30
Recruiting
Janssen Research & Development, LLC
Phase 3
1,000
Avignon, Lille, Lyon, Montpellier, Nantes, Paris, Pessac, Poitiers
2024-10-18
Active, closed
Janssen Research & Development, LLC
Phase 1
108
Lille, Lyon, Nantes, Pessac
2024-06-07
Active, closed
Janssen Research & Development, LLC
Phase 2
333
Clermont-Ferrand, Nantes, Paris, Pierre-Bénite, Reims, Strasbourg
2024-05-30
Recruiting
Janssen Research & Development, LLC
Phase 1/2
287
Avignon, Lille, Nantes, Paris, Villejuif
2024-04-22
Active, closed
Janssen Research & Development, LLC
Phase 3
838
Lille, Limoges, Lyon, Marseille, Nantes, Paris, Pessac, Strasbourg
2024-01-22
Active, closed
Janssen Research & Development, LLC
Phase 3
614
Amiens, Caen, Grenoble, Le Mans, Lille, Montpellier, Nantes, Paris
2023-03-29
Active, closed
Janssen Research & Development, LLC
Phase 3
1,135
Bordeaux, Clermont-Ferrand, Grenoble, Limoges, Lyon, Nantes, Nîmes, Orléans
2023-03-23
Active, closed
Janssen Research & Development, LLC
Phase 3
213
Caen, Nantes, Paris, Pessac
2022-12-15
Recruiting
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
NCT05652335Relapsed or Refractory Multiple Myeloma, Previously Treated Amyloid Light-chain (AL) Amyloidosis
DrugRamantamig
Janssen Research & Development, LLC
Phase 1
180
Nantes, Pierre-Bénite, Rennes, Toulouse
2022-11-22
Recruiting
Janssen Research & Development, LLC
Phase 3
1,590
Créteil, Lille, Lyon, Nantes, Paris, Pessac, Poitiers, Rennes
2022-10-25
Active, closed
Janssen Research & Development, LLC
Phase 3
864
Créteil, Dijon, Lyon, Montpellier, Nantes, Nice, Paris, Pessac
2022-10-13
Active, closed
Janssen Research & Development, LLC
Phase 2
703
Amiens, Besançon, Créteil, Grenoble, Marseille, Nantes, Neuilly-sur-Seine, Nice
2022-07-22
Active, closed
Janssen Research & Development, LLC
Phase 1
74
Montpellier, Nantes, Poitiers, Toulouse
2022-05-25
Active, closed
Janssen Research & Development, LLC
Phase 3
350
Bayonne, Besançon, Colombes, Nantes, Nice, Paris, Pierre-Bénite, Reims
2022-01-19
Active, closed
Janssen Research & Development, LLC
Phase 3
587
Créteil, Lille, Limoges, Lyon, Nantes, Poitiers, Strasbourg, Toulouse
2021-10-14
Active, closed
Janssen Research & Development, LLC
Phase 1
166
Nantes, Pessac, Rennes, Toulouse
2021-09-22
Active, closed
Janssen Research & Development, LLC
Phase 3
743
Lille, Nantes, Paris, Poitiers, Toulouse
2021-08-19
Recruiting
Janssen Research & Development, LLC
Phase 1/2
420
Besançon, Marseille, Nantes, Paris, Pessac, Pierre-Bénite, Strasbourg, Toulouse
2021-05-19
Active, closed
Janssen Research & Development, LLC
Phase 1
140
Lyon, Nantes, Pessac, Rennes, Toulouse
2021-03-12
Recruiting
Janssen Research & Development, LLC
Phase 2
510
Créteil, Lyon, Montpellier, Nantes, Pessac, Toulouse
2021-02-01
Active, closed
Janssen Research & Development, LLC
Phase 3
308
Bordeaux, Bron, Dijon, Le Mans, Lille, Nantes, Paris, Pessac
2020-10-13
Active, closed
Janssen Research & Development, LLC
Phase 2
194
Lille, Lyon, Nantes, Poitiers, Toulouse, Tours
2020-09-17
Active, closed
Janssen Research & Development, LLC
Phase 3
419
Lille, Lyon, Montpellier, Nantes, Paris, Poitiers, Toulouse
2020-06-12
Active, closed
Janssen Research & Development, LLC
Phase 2
208
Lille, Nantes, Paris
2019-11-07
Active, closed
Janssen Research & Development, LLC
Phase 2/3
118
Amiens, Brest, Dijon, La Tronche, Nantes, Poitiers
2019-08-15
Active, closed
Janssen Research & Development, LLC
Phase 3
2,517
Angers, Besançon, Bordeaux, Créteil, Lyon, Nantes, Paris, Quint-Fonsegrives
2019-06-11
Rows per page Showing 1–35 of 35
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 October 2026. https://priyalifescience.com/clinical-trials-france/city/nantes

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,697 studies in total at the last sync on 26 Oct 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 35 of those studies with a site in Nantes that also match the filters currently applied.

How many clinical trials are recruiting in Nantes?

14 of the 35 studies on this page are recruiting new participants as of the 26 Oct 2026, 03:20 UTC sync. A further 0 have not yet opened recruitment, 20 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Nantes), 35 studies
PhaseStudiesRecruitingShare
Phase 319854.3%
Phase 16117.1%
Phase 26217.1%
Phase 1/2225.7%
Phase 2/3215.7%

Most active sponsors

Lead sponsors with the most studies (Nantes)
Lead sponsorStudiesRecruiting
Janssen Research & Development, LLC3514
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.